Minimally Invasive Hemodynamic Monitoring in Cardiac Ablation
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorIstanbul University - Cerrahpasa
About this trial
This prospective observational clinical study aims to evaluate the clinical utility of Pressure Recording Analytical Method (PRAM)-based minimally invasive hemodynamic monitoring in patients undergoing cardiac ablation procedures. The study will be conducted in the cardiac catheterization laboratory of Istanbul University-Cerrahpaşa Cardiology Institute and will include 27 adult patients scheduled for catheter ablation. Written informed consent will be obtained from all participants, and the study will adhere to the principles of the Declaration of Helsinki.
Eligibility criteria
Qualifiers
Age ≥18 years
Patients scheduled for cardiac catheter ablation in the electrophysiology laboratory
Indication for ablation confirmed by a cardiologist
Ability to provide written informed consent
Disqualifiers
Refusal or inability to provide informed consent
Failure to identify arrhythmogenic focus leading to cancellation of ablation procedure
Severe hemodynamic instability prior to procedure
Contraindication to invasive arterial catheterization
Trial design
Treatments tested in this trial
- Minimally invasive hemodynamic monitoring
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov